166 related articles for article (PubMed ID: 27300747)
1. Epidemiological data of 290 pemphigus vulgaris patients: a 29-year retrospective study.
Baum S; Astman N; Berco E; Solomon M; Trau H; Barzilai A
Eur J Dermatol; 2016 Aug; 26(4):382-7. PubMed ID: 27300747
[TBL] [Abstract][Full Text] [Related]
2. Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.
Kridin K; Zelber-Sagi S; Bergman R
Acta Derm Venereol; 2017 Oct; 97(9):1095-1099. PubMed ID: 28536732
[TBL] [Abstract][Full Text] [Related]
3. HLA-DRw4 in pemphigus vulgaris patients in Israel.
Brautbar C; Moscovitz M; Livshits T; Haim S; Hacham-Zadeh S; Cohen HA; Sharon R; Nelken D; Cohen T
Tissue Antigens; 1980 Sep; 16(3):238-43. PubMed ID: 6936869
[TBL] [Abstract][Full Text] [Related]
4. Remarkable differences in the epidemiology of pemphigus among two ethnic populations in the same geographic region.
Kridin K; Zelber-Sagi S; Khamaisi M; Cohen AD; Bergman R
J Am Acad Dermatol; 2016 Nov; 75(5):925-930. PubMed ID: 27614531
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and clinical characteristics of patients with pemphigus treated in Białystok in 2001-2018.
Serwin AB; Flisiak I
Przegl Epidemiol; 2020; 74(3):457-465. PubMed ID: 33570343
[TBL] [Abstract][Full Text] [Related]
6. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
Alpsoy E; Akman-Karakas A; Uzun S
Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
[TBL] [Abstract][Full Text] [Related]
7. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
[TBL] [Abstract][Full Text] [Related]
8. Pemphigus--analysis of epidemiological factors in 155 patients.
Mimouni D; Bar H; Gdalevich M; Katzenelson V; David M
J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1232-5. PubMed ID: 18482324
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus vulgaris: a clinical study of 44 cases over a 20-year period.
Svecova D
Int J Dermatol; 2015 Oct; 54(10):1138-44. PubMed ID: 26394602
[TBL] [Abstract][Full Text] [Related]
10. Influence of treatment on the clinical course of pemphigus vulgaris.
Carson PJ; Hameed A; Ahmed AR
J Am Acad Dermatol; 1996 Apr; 34(4):645-52. PubMed ID: 8601655
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of autoimmune bullous diseases in Iran: a 10-year review.
Daneshpazhooh M; Chams-Davatchi C; Payandemehr P; Nassiri S; Valikhani M; Safai-Naraghi Z
Int J Dermatol; 2012 Jan; 51(1):35-41. PubMed ID: 22182376
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients.
Bozdag K; Bilgin İ
Cutan Ocul Toxicol; 2012 Dec; 31(4):280-5. PubMed ID: 22309241
[TBL] [Abstract][Full Text] [Related]
13. Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews.
Brenner B; Fried G; Levitzki P; Rakowsky E; Lurie H; Idelevich E; Neuman A; Kaufman B; Sulkes J; Sulkes A
Cancer; 2002 Apr; 94(8):2128-33. PubMed ID: 12001108
[TBL] [Abstract][Full Text] [Related]
14. Temporal course of avascular femoral head necrosis in patients with pemphigus vulgaris.
Balighi K; Daneshpazhooh M; Aghazadeh N; Saeidi V; Shahpouri F; Hejazi P; Chams-Davatchi C
J Dtsch Dermatol Ges; 2016 Oct; 14(10):1016-1021. PubMed ID: 27767268
[TBL] [Abstract][Full Text] [Related]
15. HLA antigens in Jews with pemphigus vulgaris.
David M; Zamir R; Segal R; Gazit E; Feuerman EJ
Dermatologica; 1981; 163(4):326-30. PubMed ID: 7308553
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
Baum S; Greenberger S; Samuelov L; Solomon M; Lyakhovitsky A; Trau H; Barzilai A
Eur J Dermatol; 2012; 22(1):83-7. PubMed ID: 22266247
[TBL] [Abstract][Full Text] [Related]
17. HLA DRB1* and DQB1* alleles are associated with disease severity in patients with pemphigus vulgaris.
Svecova D; Parnicka Z; Pastyrikova L; Urbancek S; Luha J; Buc M
Int J Dermatol; 2015 Feb; 54(2):168-73. PubMed ID: 24602055
[TBL] [Abstract][Full Text] [Related]
18. The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.
Lyakhovitsky A; Baum S; Scope A; Amichai B; Barzilai A; Rimer J; Trau H
Int J Dermatol; 2011 Aug; 50(8):1014-9. PubMed ID: 21781080
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus in Israel--an epidemiologic analysis of cases in search of risk factors.
Wohl Y; Brenner S
Isr Med Assoc J; 2003 Jun; 5(6):410-2. PubMed ID: 12841011
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Pemphigus in Turkey: One-year Prospective Study of 220 Cases.
Yayli S; Harman M; Baskan EB; Karakas AA; Genc Y; Turk BG; Demirsoy EO; Gunasti S; Bilgili SG; Ilter N; Ferahbas A; Savk E; Afsar FS; Aytekin S; Kaya TI; Hayta SB; Ozgen Z; Gurel MS; Caliskan E; Balci DD; Gungor S; Kapicioglu Y; Ozuguz P; Aktan S; Dogramaci A; Kokcam I; Onsun N; Seckin D; Durdu M; Dursun R; Daye M; Dilek N; Karabacak E; Temel AB; Erdem C; Altun E; Gungor D; Kartal D; Akyol M; Koku Aksu EK; Uzun S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):181-188. PubMed ID: 29252169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
